ADVERTISEMENT
Insurers Say Tennis Player s $9.9M Arbitration Isn t Covered
Law360 (May 5, 2021, 2:36 PM EDT) The touring company for the Women s Tennis Association can t tap into coverage for an American professional tennis player s $9.9 million arbitration over the way antidoping blood tests are administered at tournaments, according to insurers Florida federal suit.
Depositors Insurance Co. and Allied Property & Casualty Insurance Co. said Tuesday that their business owners policy and umbrella policy exclude the type of professional services the insertion of a needle into a vein for blood testing at issue in Madison Brengle s arbitration against WTA Tour Inc.
Brengle said WTA Tour forced her at various major tennis tournaments to undergo venipuncture blood.